Our Vision

At Abraxis Oncology, our vision is to improve and enhance the lives of cancer patients by leveraging proprietary core technologies, such as nanoparticle albumin-bound (nab™) technology, to make effective cancer therapies better and to bring new oncology agents to market.

"Our primary goal at Abraxis Oncology is to provide new treatment options that will improve the lives of patients facing cancer–utilizing what is known about cancer biology to develop revolutionary therapeutics."

— Carlo Montagner, President, Abraxis Oncology